Edge Wealth Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-121,295
| Closed | -$1.15M | – | 440 |
|
|
2020
Q3 | $1.15M | Buy |
121,295
+2,894
| +2% | +$27.3K | 0.26% | 51 |
|
|
2020
Q2 | $1.06M | Sell |
118,401
-13,620
| -10% | -$122K | 0.2% | 66 |
|
|
2020
Q1 | $820K | Buy |
132,021
+61,244
| +87% | +$380K | 0.18% | 70 |
|
|
2019
Q4 | $590K | Buy |
70,777
+1,908
| +3% | +$15.9K | 0.12% | 93 |
|
|
2019
Q3 | $623K | Hold |
68,869
| – | – | 0.14% | 85 |
|
|
2019
Q2 | $736K | Sell |
68,869
-1,931
| -3% | -$20.6K | 0.16% | 81 |
|
|
2019
Q1 | $675K | Buy |
70,800
+20,930
| +42% | +$200K | 0.17% | 84 |
|
|
2018
Q4 | $573K | Sell |
49,870
-1,810
| -4% | -$20.8K | 0.16% | 80 |
|
|
2018
Q3 | $876K | Buy |
51,680
+11,667
| +29% | +$198K | 0.21% | 68 |
|
|
2018
Q2 | $568K | Buy |
+40,013
| New | +$568K | 0.14% | 89 |
|